Cell adhesion mediated drug resistance (CAM-DR): Role of integrins and resistance to apoptosis in human myeloma cell lines

Blood

Volumn 93, Issue 5, 1999, Pages 1658-1667

  Damiano, Jason S ^b   Cress, Anne E ^b   Hazlehurst, Lori A ^b   Shtil, Alexander A ^b   Dalton, William S ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; DOXORUBICIN; INTEGRIN; MELPHALAN; RECEPTOR; VERY LATE ACTIVATION ANTIGEN 5;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL SURVIVAL; CONTROLLED STUDY; DRUG RESISTANCE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MYELOMA CELL; PHENOTYPE; PRIORITY JOURNAL;

EID: 0033105537     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.5.1658.405a19_1658_1667     Document Type: Article

References (67)

1. Schustik C, Dalton WS, Gros P: P-glycoprotein-mediated multidrug resistance in tumor cells: Biochemistry, clinical relevance and modulation, in: Molecular Aspects of Medicine, vol 16. London, UK, Elsevier Science, 1995, p 1
2. Dalton WS, Grogan TM, Rybski JA, Scheper RJ, Richter L, Kailey J, Broxterman HJ, Pinedo HM, Salmon SE: Immunohistochemical detection and quantification of P-glycoprotein in multiple drug-resistant human myeloma cells: Association with level of drug resistance and drug accumulation. Blood 73:747, 1989
3. Durand RE, Sutherland RM: Effects of intercellular contact on repair of radiation damage. Exp Cell Res 71:75, 1972
4. Teicher BA, Herman TS, Holden SA, Wang Y, Pfeffer MR, Crawford JW, Frei E III: Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science 247:1457, 1990
5. Meredeth JE, Fazeli B, Schwartz MA: The extracellular matrix as a cell survival factor. Mol Biol Cell 4:953, 1993
6. Bates RC, Buret A, van Helden DF, Horton MA, Burns GF: Apoptosis induced by inhibition of intercellular contact. J Cell Biol 125:403, 1994
7. Frisch SM, Hunter F: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124:619, 1994
8. kip1 on resistance of tumor cells to anticancer agents. Nature Med 2:1204, 1996
9. Schuetz JD, Schuetz EG: Extracellular matrix regulation of multidrug resistance in primary monolayer cultures of adult rat hepatocytes. Cell Growth Diff 4:31, 1993
10. Dedhar S: Integrin mediated signal transduction in oncogenesis: An overview. Cancer Metas Rev 14:55, 1996
11. Juliano R: Signal transduction by integrins and its role in the regulation of tumor growth: Cancer Metas Rev 13:25, 1994
12. Clark EA, Brugge JS: Integrins and signal transduction pathways: The road taken. Science 268:233, 1995
13. Higashimoto I, Chihara J, Kakazu T, Kawabata M, Nakajima S, Osame M: Regulation of eosinophil cell death by adhesion to fibronectin. Int Arch Allergy Immunol 111:66, 1996 (Suppl 1)
14. Zhang Z, Vuori K, Reed JC, Rouslahti E: The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci USA 92(13):6161, 1995
15. Scott G, Cassidy L, Busacco A: Fibronectin suppresses apoptosis in normal human melanocytes through an integrin-dependent mechanism. J Invest Dermatol 108:147, 1997
16. Rozzo C, Chiesa C, Caridi G, Pagnan G, Ponzoni M: Induction of apoptosis in human neuroblastoma cells by abrogation of integrin-mediated cell adhesion. Int J Cancer 70:688, 1997
17. Hoyt DG, Rusnak JM, Mannix RJ, Modzelewski RA, Johnson CS, Lazo JS: Integrin activation suppresses etoposide-induced DNA strand breakage in cultured murine tumor-derived endothelial cells. Cancer Res 56:2146, 1996
18. Fuks Z, Vlodavsky I, Andreeff M, McLoughlin M, Haimovitz-Friedman A: Effects of extracellular matrix on the response of endothelial cells to radiation in vitro. Eur J Cancer 28A:725, 1992
19. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11, 1992
20. Jensen GS, Belch AR, Mant MJ, Ruether BA, Tacyshyn BR, Pilarsky LM: Expression of multiple β1 integrins on circulating monoclonal B cells in patients with multiple myeloma. Am J Hematol 43:29, 1993
21. Barker HF, Ball J, Drew M, Hamilton MS, Franklin IM: The role of adhesion molecules in multiple myeloma. Leuk Lymph 8:189, 1992
22. Pulido R, Elices MJ, Campanero MR, Osborn L, Schiffer S, Garcia-Pardo A, Lobb R, Hemler ME, Sanchez-Madrid F: Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. J Biol Chem 266:10241, 1991
23. Elices MJ, Osbom L, Takada Y, Crouse C, Lujowskyj S, Hemler ME, Lobb RR: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60:577, 1990
24. Anwar ARF, Moqbel R, Walsh GM, Kay AB, Wardlaw AJ: Adhesion to fibronectin prolongs eosinophil survival. J Exp Med 177:839, 1993
25. Wang MW-J, Consoli U, Lane CM, Durett A, Lauppe MJ, Champlin R, Andreeff M, Deisseroth AB: Rescue from apoptosis in early (CD34-selected) versus late (non-CD-34-selected) human hematopoietic cells by very later antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cells. Cell Growth Diff 9:105, 1998
26. Koopman G, Keehen RMJ, Lindhout E, Newman W, Shimizu Y, van Seventer GA, de Groot C, Pals ST: Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. J Immunol 152:3760, 1994
27. Saiki I, Yoneda J, Kobayashi H, Igarashi Y, Komazawa H, Ishizaki Y, Kato I, Azuma I: Antimetastatic effect by anti-adhesion therapy with cell-adhesive peptide of fibronectin in combination with anticancer drugs. Jpn J Cancer Res 84:326, 1993
28. Caligaris-Cappio F, Gregoretti MG, Merico F, Gorrardi D, Ghia P, Parvis G, Bergui L: Bone marrow microenvironment and the progression of multiple myeloma. Leuk Lymph 8:15, 1992
29. Bataille R, Chappard D, Klein B: The critical role of IL-6 and macrophage colony stimulating factor in the pathogenesis of bone lesions in multiple myeloma. Int J Clin Lab Res 21:283, 1992
30. Uchiyama H, Barut BA, Mohrbacher AF, Chauhan D, Anderson KC: Adhesion of human myeloma cell lines to bone marrow stromal cells stimulates IL-6 secretion. Blood 82:3712, 1993
31. Xiao J, Messinger Y, Jin J, Myers DE, Bolen JB, Uckun FM: Signal transduction through the beta 1 integrin family surface adhesion molecules VLA-4 and VLA-5 of human B-cell precursors activates CD19 receptor-associated protein-tyrosine kinases. J Biol Chem 271(13): 7659, 1996
32. FAK) is tyrosine phosphorylated after engagement of α4β1 and α5β1 integrins on human t-lymphoblastic cells. Cell Immunol 161:8, 1995
33. FAK): A point of convergence in the action of neuropeptides, integrins, and oncogenes. Cell 71:891, 1992
34. Chen H-C, Guan J-L: Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 91:10148, 1994
35. Frisch SM, Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124:619, 1994
36. Hungerford JE, Compton MT, Matter ML, Hoffstrom BG, Otey CA: Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J Cell Biol 135:1383, 1996
37. Wen LP, Fahrni JA, Troie S, Guan JL, Orth K, Rosen GD: Cleavage of focal adhesion kinase by caspases during apoptosis. J Biol Chem 272:26056, 1997
38. Dalton WS, Durie BGM, Alberts DS, Gerlach JH, Cress AE: Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein. Cancer Res 46:2125, 1986
39. Bellamy WT, Dalton WS, Gleason MC, Grogan TM, Trent JM: Development and characterization of a melphalan resistant human multiple myeloma cell line. Cancer Res 51:995, 1991
40. Tu Y, Xu F, Liu J, Vescio R, Berenson J, Fady C, Lichtenstein A: Upregulated expression of Bcl-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide. Blood 88:1805, 1996
41. Futscher BW, Blake LL, Gerlach JH, Grogan TM, Dalton WS: Quantitative polymerase chain reaction analysis of MDR1 mRNA in multiple myeloma cell lines and clinical specimens. Anal Biochem 213:414, 1993
42. Benito A, Silver M, Grillot D, Nunez G, Fernandez-Luna JL: Apoptosis induced by erytheroid differentiation of human leukemia cell lines is inhibited by Bcl-XL. Blood 87:3837, 1996
43. Abbaszadegan MR, Futscher BW, Klimecki WT, List A, Dalton WS: Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematapoietic cells. Cancer Res 54:4676, 1994
44. Komarov P, Shtil A, Holian O, Tee L, Buckingham L, Mechetner E, Roninson I, Coon J: Activation of the LRP (lung resistance-associated protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine. Oncology Res 10:185, 1998
45. Vichi P, Tritton TR: Stimulation of growth in human and murine cells by adriamycin. Cancer Res 49:2679, 1989
46. Bozzo C, Bellomo G, Silengo L, Tarone G, Altruda F: Soluble integrin ligands and growth factors independently rescue neuroblastoma cells from apoptosis under nonadherent conditions. Exp Cell Res 237:326, 1997
47. Abbaszadegan MR, Cress AE, Futscher BW, Bellamy WT, Dalton WS: Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensisitzers. Cancer Res 56(23):5435, 1996
48. Duensing S, Brevis Nunez F, Meyer N, Anastassiou G, Nasarek A, Grosse J, Buer J, Probst M, Ganser A, Alzpodien J: Exposure to vinblastine modulates beta 1 integrin expression and in vitro binding to extracellular matrix molecules in a human renal carcinoma cell line. Invasion Met 16:65, 1996
49. Sedlak J, Sedlakova O, Hlavcak P, Hunakova L, Bizik J, Grofova M, Chorvath B: Cell surface phenotype and increased penetration of human multidrug-resistant ovarian carcinoma cells into in vitro collagen-fibroblasts matrix. Neoplasma 43:389, 1996
50. Scotlandi K, Serra M, Nicoletti G, Vaccari M, Cristina Manara M, Nini G, Landuzzi L, Colacci A, Bacci G, Bertoni F, Picci P, Campanacii M, Baldini N: Multidrug resistance and malignancy in human osteosarcoma. Cancer Res 56:2434, 1996
51. Nista A, Leonetti C, Bernardini G, Mattoni M, Santoni A: Functional role of a4b1 and a5b1 integrin fibronectin receptors expressed on adriamycin-resistant MCF-7 human mammary carcinoma cells. Int J Cancer 72:133, 1997
52. Altevogt P, Hubbe M, Ruppert M, Lohr J, Von Hoegen P, Sammar M, Andrew DP, McEvoy L, Humphries MJ, Butcher EC: The α4 integrin chain is a ligand for α4β7 and α4β1. J Exp Med 182:345, 1995
53. Van Riet I, De Greef C, Del Favero H, Demanet C, Van Camp B: Production of fibronectin and adherence to fibronectin by human myeloma cell lines. Br J Hematol 87:258, 1994
54. Paizi M, Manaster J, Quitt M, Spira G: High plasma fibronectin levels in multiple myeloma patients: Possible mechanism and clinical implications. Scand J Immunol 34:285, 1991
55. Soose M, Wenzel S, Padur A, Oberst D, Stolte H: Fibronectin expression in human mesangial cell cultures and its alteration by adriamycin. Cell Biol Toxicol 11:51, 1995
56. Dalton WS: Detection of multidrug resistance gene expression in multiple myeloma. Leukemia 11(7):1165, 1997
57. Rodeck U, Jost M, DuHadaway J, Kari C, Jensen PJ, Risse B, Ewert DL: Regulation of Bcl-x1 expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor. Proc Natl Acad Sci USA 94:5067, 1997
58. Hurley RW, McCarthy JB, Verfaillie CM: Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest 96:511, 1995
59. Kennedy SG, Wagner AJ, Conzen SD, Jordan J, Bellacosa A, Tsichlis PN, Hay N: The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Devel 11:701, 1997
60. Marte BM, Downward J: PKB/Akt: Connecting phophonisositide 3-kinase to cell survival and beyond. TIBS 22:355, 1997
61. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 92:231, 1997
62. Scheid MP, Lauener RW, Duronio V: Role of phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in haemopoietic cells: Phosphatidylinositol 3-OH-kinase inhibitors reveal a difference in signalling between interleukin-3 and granulocyte-macrophage colony stimulating factor. Biochem J 312:159, 1995
63. 2+ mobilization. Eur J Immunol 27:1530, 1997
64. King WG, Mattaliano MD, Chan TO, Tsichlis RN, Brugge JS: Phosphatidylinositol 3-kinase is required for integrin stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol Cell Biol 17(8):4406, 1997
65. Morimoto C, Iwata S, Tachibana K: VLA-4-mediated signaling. Curr Opin Micro Immunol 231:1, 1998
66. Chen Q, Kinch MS, Lin TH, Burridge K, Juliano RL: Integrin-mediated cell adhesion activates mitogen-activated protein kinases. J Biol Chem 269:26602, 1994
67. Boudreau N, Sympson CJ, Werb Z, Bissell MJ: Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267(5199): 891, 1995